]>
IRCT20140907019073N4 IRCT 2020-03-29 Iran University of Medical Sciences Evaluation of the effectiveness of Ipecac homeopathic remedy in control of Clinical manifestations of COVID-19 Double blind clinical trial study on Evaluation of the effectiveness of Ipecac homeopathic remedy in control of Clinical manifestations of COVID-19 2020-04-03 anticipated 60 Complete https://irct.ir/trial/46736 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Firstly patients are divided into moderate and severe groups to match the severity of the disease then according to computerized block randomization division is performed, Blinding description: Bottles are numbered in each group and finally according to computerized block randomization division is performed , the remedies and placebo put on the numbered bottles by one of researchers who is only person that know about this concealment. Every patient admitted to the ward and who wants to participate this survey take this bottles respectively. Patients, therapist and evaluator does not know the true contents of the bottles(which have equal taste and odor) and the study is double-blinded. 3 covid-19. Intervention 1: The one globule of (Ipecac)homeopathy remedy with C30 potency produced by Hellios homeopathy pharmacy distilled in 20 ml. 10 degree alcohol which will be administered at a dose of 15 drops every 2 hours for 6 hours and then every 6hours at 15 drops for 3 days. Intervention 2: The one placebo(Sac-lac) distilled in 20 ml. 10 degree alcohol which will be administered at a dose of 15 drops every 2 hours for 6 hours and then 15 drops every 6 hours for 3 days. remedy and placebo have both common bases and are similar in taste, color, odor and taste. Yes - There is a plan to make this available What will be shared: IPD collection for the primary and secondary outcomes When: immediately after publication To whom: people working in academic institution Conditions: The result of further analysis may not be presented to public without permission Where to obtain: mazaheri.a@iums.ac.ir mazaherinezhad@gmail.com mahroozade.a@iums.ac.ir How to obtain: A reasonable request from an academic source will be responded within 14 working days Comments:
public Farbod Rahnama Chitsaz
No. 119 Shahid Farshi Moqaddam street(16th)
Tehran Iran (Islamic Republic of) 1439837953 +98 21 8413 0001 farbod.chitsaz@gmail.com Medical Council of Iran scientific Ali Mazaherinezhad
Hemat Highway next to Milad Tower. Iran University of Medical Sciences
Tehran Iran (Islamic Republic of) ۱۴۴۹۶۱۴۵۳۵ +98 21 86701 Mazaheri.a@iums.ac.ir Iran University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Suspected or uncertain cases of patients admitted to one of Rasoul-e-Akram or Firoozgar Hospitals with a diagnosis of Covid19 (based on national Guideline). no limit no limit Both Patients should not be intubated. Patient should not be immune defective. U07.1 Covid-19 Treatment - Drugs Placebo The one globule of (Ipecac)homeopathy remedy with C30 potency produced by Hellios homeopathy pharmacy distilled in 20 ml. 10 degree alcohol which will be administered at a dose of 15 drops every 2 hours for 6 hours and then every 6hours at 15 drops for 3 days. The one placebo(Sac-lac) distilled in 20 ml. 10 degree alcohol which will be administered at a dose of 15 drops every 2 hours for 6 hours and then 15 drops every 6 hours for 3 days. remedy and placebo have both common bases and are similar in taste, color, odor and taste. Fever. Timepoint: The first day, the second day, the third day. Method of measurement: Check body temperature with thermometer. Cough. Timepoint: The first day, the second day, the third day. Method of measurement: Physician report. Shortness of breath. Timepoint: The first day, the second day, the third day. Method of measurement: Patient Report. Chills. Timepoint: The first day, the second day, the third day. Method of measurement: Patient Report. Myalgia. Timepoint: The first day, the second day, the third day. Method of measurement: Patient Report. O2 arterial blood saturation. Timepoint: The first day, the second day, the third day. Method of measurement: Pulse Oximeter Report. Number of lymphocytes. Timepoint: The first day, the second day, the third day. Method of measurement: Blood test. Serum CRP. Timepoint: The first day, the second day, the third day. Method of measurement: Blood test. Need ventilator. Timepoint: The first day, the second day, the third day. Method of measurement: Physician diagnosis. The amount of oxygen received. Timepoint: The first day, the second day, the third day. Method of measurement: Manometer view. Oxygen Intake Method. Timepoint: The first day, the second day, the third day. Method of measurement: Observation. Iran University of Medical Sciences Approved 2020-03-26 Ethics committee of Iran University of Medical Sciences Iran University of Medical sciences, south side of Hemmat highway, Tehran, Iran. Tehran Tehran Iran (Islamic Republic of)